dexmedetomidine (Q412133)

has use

medication

0 references

chemical structure

Dexmedetomidine.svg
512 × 254; 2 KB

0 references

1 reference

C₁₃H₁₆N₂

1 reference

DEXMEDETOMIDINE (English)

19 November 2016

canonical SMILES

CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C

1 reference

DEXMEDETOMIDINE (English)

19 November 2016

isomeric SMILES

CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C

1 reference

DEXMEDETOMIDINE (English)

parenteral route of administration

19 November 2016

defined daily dose

1 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=N05CM18

1 reference

14 February 2018

World Health Organisation international non-proprietary name

dexmedetomidine (English)

1 reference

dexmedetomidine (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

agitation in dementia

1 reference

significant drug interaction

13 December 2016

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Adrenoceptor alpha 2A

subject has role

agonist

1 reference

17 August 2016

Adrenoceptor alpha 2B

subject has role

agonist

1 reference

17 August 2016

Adrenoceptor alpha 2C

subject has role

agonist

1 reference

imported from Wikimedia project

17 August 2016

pregnancy category

US pregnancy category C

1 reference

English Wikipedia

mass

200.131349 dalton

1 reference

DEXMEDETOMIDINE (English)

3 October 2016

1 reference

Medical Subject Headings

MeSH descriptor ID

D020927

Adrenergic alpha-2 Receptor Agonists

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D020927

15 March 2018

hypnotics and sedatives

1 reference

InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1

Medical Subject Headings

15 March 2018

Dexmedetomidine

0 references

Identifiers

InChI

1 reference

DEXMEDETOMIDINE (English)

19 November 2016

2 references

DEXMEDETOMIDINE (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

113775-47-6

2 references

dexmedetomidine (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=113775-47-6

9 April 2021

1 reference

Dexmedetomidine (English)

19 November 2016

2 references

DEXMEDETOMIDINE (English)

19 November 2016

Reaxys registry number

5906875

1 reference

dexmedetomidine (English)

3 October 2016

ChEBI ID

4466

mapping relation type

2 references

DEXMEDETOMIDINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1

1 reference

DEXMEDETOMIDINE (English)

19 November 2016

2 references

26433

2 references

1 reference

1 reference

DSSTOX compound identifier

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.119.391

27 December 2018

ECHA Substance Infocard ID

5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole (English)

quotation

CAS no.: 113775-47-6 (English)

100.119.391

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.119.391

27 December 2018

5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole (English)

quotation

CAS no.: 113775-47-6 (English)

1 reference

Dexmedetomidine (English)

publication date

23 September 2015

1 reference

dexmedetomidine (English)

19 November 2016

Dexmedetomidine

0 references

0 references

0 references

1 reference

dexmedetomidine (English)

19 November 2016

DrugBank ID

DB00633

1 reference

Human Metabolome Database ID

HMDB0014771

2 references

2 references

dexmedetomidine (English)

19 November 2016

NDF-RT ID

N0000148660

1 reference

dexmedetomidine (English)

19 November 2016

0 references

1 reference

1 reference

dexmedetomidine (English)

3 October 2016

1 reference

Microsoft Academic ID (discontinued)

dexmedetomidine (English)

3 October 2016

0 references

1 reference

28 October 2013

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI

C0113293

1 reference

dexmedetomidine (English)

19 November 2016

C0752311

1 reference

inferred by common MeSH mappings on source and on Wikidata

25 May 2023

0 references

subject named as (monolingual text)

dexmedetomidin (Swedish)

deksmedetomidiini (Finnish)

dexmedetomidine (English)

alternative name (monolingual text)

dexmetomidin (Swedish)

1 reference